Your browser doesn't support javascript.
loading
Long-term outcomes of gastric electrical stimulation in children with gastroparesis.
Islam, Saleem; McLaughlin, Jillian; Pierson, Justine; Jolley, Christopher; Kedar, Archana; Abell, Thomas.
Affiliation
  • Islam S; Division of Pediatric Surgery, Department of Surgery, University of Florida College of Medicine, Gainesville, FL, United States. Electronic address: saleem.islam@surgery.ufl.edu.
  • McLaughlin J; Division of Pediatric Surgery, Department of Surgery, University of Florida College of Medicine, Gainesville, FL, United States.
  • Pierson J; Division of Plastic Surgery, Department of Surgery, University of Florida College of Medicine, Gainesville, FL, United States.
  • Jolley C; Division of Pediatric Gastroenterology, Department of Pediatrics, University of Florida College of Medicine, Gainesville, FL, United States.
  • Kedar A; Internal Medicine, University of Mississippi Medical Center, Jackson, MS, United States.
  • Abell T; Division of Gastroenterology, Department of Medicine, University of Louisville, Louisville, KY, United States.
J Pediatr Surg ; 51(1): 67-71, 2016 Jan.
Article in En | MEDLINE | ID: mdl-26526207
ABSTRACT

BACKGROUND:

Gastric electrical stimulation (GES) has been used in adults with gastroparesis. However its use has been limited in children. We describe the largest experience with GES in children with long-term outcomes.

METHODS:

Data were collected on children who underwent GES over a 10-year period. Data regarding demographics, medical history, hospital course, and outcomes were collected and analyzed. Symptom scores (validated Likert scores) were compared using a paired Student's t test.

RESULTS:

Overall, 97 patients underwent GES, and a majority were teenage Caucasian girls. Ninety-six had temporary GES (tGES), and 66 had improvement in their symptoms. A total of 67 underwent permanent implantation (pGES), and there was significant reduction in all individual symptoms (p<0.001) as well as the total symptom score (TSS) (p<0.0001) at 1, 6, 12, and >12 months. Recurrence of symptoms leading to device removal occurred in 7 cases. Forty-one patients had continued improvement in symptoms for over 12 months, with a mean follow-up of 3.5 years (range 1-9 years).

CONCLUSIONS:

This study represents the largest experience of systematic application of GES in children. GES is a safe and effective therapy for selected children with intractable GP with continued symptomatic improvement at 1 year and beyond.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Electric Stimulation Therapy / Gastroparesis Type of study: Observational_studies / Prognostic_studies Language: En Journal: J Pediatr Surg Year: 2016 Type: Article

Full text: 1 Database: MEDLINE Main subject: Electric Stimulation Therapy / Gastroparesis Type of study: Observational_studies / Prognostic_studies Language: En Journal: J Pediatr Surg Year: 2016 Type: Article